Finding accredited CPD
In this webinar, an expert multidisciplinary panel will apply Australian T2D guidance to a framework for identifying and managing patients with T2D who can benefit from clinical review or treatment intensification, from newly diagnosed patients requiring early, individualised management through to those with persistent above-target glycaemia despite established treatment.¹⁻² Through four patient cases, the panel will explore individualised HbA1c targets, early risk-factor management, therapeutic inertia, treatment initiation and intensification, the role of SGLT2 inhibitors (SGLT2i) and GLP-1 receptor agonists (GLP-1 RA), cardiorenal risk, monitoring, and recall.¹⁻²
The webinar features a live Q&A which will allow participants to ask their challenging clinical cases and conundrums. Supported by the expert panel, participants will work through clinical scenarios and receive practical actions that can be applied in comprehensive general practice.
References
Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.
Upon completion of the learning, your CPD activity record will be automatically updated within 24 hours and reflected on your CPD Dashboard. Your Certificate of Completion will be available from your CPD Activities - Completions list. If your CPD record has not been updated after this time, please contact the education provider for assistance.
Provided by
Educational Activities (EA) - 1.30
Reviewing Performance (RP) - 0.0
Measuring Outcomes (MO) - 0.0
You have to log in to see the content of this module.
*Medical Board of Australia's (MBA)'s Registration Standard: Continuing professional development (the Standard)